AI assistant
Vir Biotechnology, Inc. — Director's Dealing 2019
Oct 10, 2019
32538_dirs_2019-10-10_2460cef2-7472-4b91-93c5-1706b7834d68.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 3 — Initial Statement of Beneficial Ownership
Issuer: Vir Biotechnology, Inc. (VIR)
CIK: 0001706431
Period of Report: 2019-10-10
Reporting Person: Abu Dhabi Investment Authority (10% Owner)
Reporting Person: Platinum International Investment Holding RSC Ltd (10% Owner)
Reporting Person: Platinum Falcon B 2018 RSC Ltd (10% Owner)
Holdings (Derivative)
| Security | Exercise Price | Expiration | Underlying | Shares | Ownership |
|---|---|---|---|---|---|
| Series A-1 Preferred Stock | $ | Common Stock (1333333) | Direct | ||
| Series B Preferred Stock | $ | Common Stock (1333333) | Direct |
Footnotes
F1: Each share of the issuer's Series A-1 Preferred Stock will automatically convert to one share of the issuer's Common Stock immediately upon the closing of the issuer's initial public offering (IPO) and has no expiration date. No fractional shares shall be issuable upon conversion.
F2: Each share of the issuer's Series B Preferred Stock will automatically convert to one share of the issuer's Common Stock immediately upon the closing of the issuer's IPO and has no expiration date. No fractional shares shall be issuable upon conversion.
F3: Platinum Falcon B 2018 RSC Ltd. ("Platinum Falcon") directly holds the Series A-1 Preferred Stock and Series B Preferred Stock. Platinum International Investment Holding RSC Limited ("Platinum Holdings") is the sole owner of Platinum Falcon, and the Abu Dhabi Investment Authority ("ADIA" and, together with Platinum Falcon and Platinum Holdings, the "Reporting Persons") is the sole owner of Platinum Holdings. Therefore, Platinum Holdings and ADIA may also be deemed to beneficially own the Series A-1 Preferred Stock and Series B Preferred Stock. Pursuant to Rule 16a-1(a)(4) under the Securities Exchange Act of 1934, as amended (the "Exchange Act"), this filing shall not be deemed an admission that the Reporting Persons are, for purposes of Section 16 of the Exchange Act or otherwise, the beneficial owners of any equity securities in excess of their respective pecuniary interests.